ASRT
HEALTHCAREAssertio Holdings Inc
$22.20+0.04 (+0.18%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ASRT Today?
No stock-specific AI insight has been generated for ASRT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$8.61$22.50
$22.20
Fundamentals
Market Cap$143M
P/E Ratio—
EPS$-4.74
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin-0.3%
Debt / Equity—
Trading
Volume211K
Avg Volume (10D)—
Shares Outstanding6.4M
ASRT News
21 articles- Assertio (NASDAQ: ASRT) investors approve 2014 plan share increaseStock Titan·May 7, 2026
- Assertio and Garda Mutually Agree to Postpone Commencement of Tender OfferYahoo Finance·May 5, 2026
- Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last?Yahoo Finance·May 5, 2026
- How The Assertio Holdings (ASRT) Story Is Shifting With The Garda Takeover And Valuation AnchorYahoo Finance·May 5, 2026
- Assertio Announces Amended and Restated Merger Agreement with Garda TherapeuticsYahoo Finance·May 4, 2026
- Are Medical Stocks Lagging Assertio (ASRT) This Year?Yahoo Finance·Apr 30, 2026
- Assertio and Garda Mutually Agree to Extend Tender Offer DeadlineYahoo Finance·Apr 29, 2026
- Assertio Provides Update on Garda Therapeutics Tender ProcessYahoo Finance·Apr 21, 2026
- How The Assertio Holdings (ASRT) Story Is Shifting With The Takeover And Reset ValuationYahoo Finance·Apr 20, 2026
- Does Assertio (ASRT) Have the Potential to Rally 115.05% as Wall Street Analysts Expect?Yahoo Finance·Apr 9, 2026
- Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?Yahoo Finance·Apr 9, 2026
- Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from AssertioYahoo Finance·Apr 8, 2026
- Assertio Announces Agreement to be Acquired by Garda TherapeuticsYahoo Finance·Apr 8, 2026
- Assertio Holdings (ASRT) Issues 2026 Sales Guidance After Wider 2025 Losses Has The Bull Case Changed?Yahoo Finance·Mar 28, 2026
- Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?Yahoo Finance·Mar 25, 2026
- Wall Street Analysts Predict an 182.79% Upside in Assertio (ASRT): Here's What You Should KnowYahoo Finance·Mar 24, 2026
- Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?Yahoo Finance·Mar 24, 2026
- Assertio Holdings Inc (ASRT) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...Yahoo Finance·Mar 17, 2026
- Assertio Holdings, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 17, 2026
- Assertio Q4 Earnings Call HighlightsMarketbeat·Mar 16, 2026
- Assertio (ASRT) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 16, 2026
All 21 articles loaded
Price Data
Open$22.16
Previous Close$22.16
Day High$22.25
Day Low$21.90
52 Week High$22.50
52 Week Low$8.61
52-Week Range
$8.61$22.50
$22.20
Fundamentals
Market Cap$143M
P/E Ratio—
EPS$-4.74
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin-0.3%
Debt / Equity—
Trading
Volume211K
Avg Volume (10D)—
Shares Outstanding6.4M
About Assertio Holdings Inc
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medications in the areas of neurology, hospital, and pain and inflammation. The company is headquartered in Lake Forest, Illinois.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—